Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis [Phase 2]
This Phase 2 trial update reports results for clemastine fumarate as a remyelinating agent in relapsing-remitting multiple sclerosis, with r…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis [Phase 2]
Phase IIa trial of Ublituximab in relapsing forms of multiple sclerosis completed; results posted.
-
FDA approval · 2021-07-13FDA Approved: BACLOFEN — Original Application (Medcore LLC)
FDA approves Medcore LLC's original ANDA for generic baclofen (oral) for the treatment of spasticity associated with multiple sclerosis and …
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis [Phase 3]
A Phase 3 head-to-head trial comparing oral ponesimod with teriflunomide in relapsing multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Home Based Infusions for Ocrelizumab [Phase 4]
Phase 4 clinical trial evaluating home-based infusions of ocrelizumab for multiple sclerosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Evaluation of the Onset of Action in Highly Active MS (MAGNIFY) [Phase 4]
Phase 4 clinical trial update evaluating onset of action in highly active multiple sclerosis; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Videofluoroscopic Swallowing Study (VFSS) [NA]
A Videofluoroscopic Swallowing Study (VFSS) trial sponsored by Nestlé has been terminated; results were posted in 2021 and the study covered…
-
CLINICAL_TRIALS research · 2021-05-19Clinical Trial Update: Idebenone for Primary Progressive Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update on idebenone for primary progressive multiple sclerosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) [Phase 3]
A Phase 3 study comparing ponesimod to placebo in active relapsing multiple sclerosis patients already treated with dimethyl fumarate was te…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis [NA]
A completed clinical trial evaluating neuromuscular electrical stimulation and mobility in multiple sclerosis; results posted in 2021.
-
FDA approval · 2021-04-30FDA Approved: BACLOFEN — Supplemental Application (Method Pharmaceuticals LLC)
The FDA approved a supplemental application for Baclofen submitted by Method Pharmaceuticals LLC under ANDA212378. This action approves a su…
-
FDA approval · 2021-04-30FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
The FDA approved a supplemental application for Aubagio (teriflunomide) by Genzyme Corporation. The submission status is AP.
-
FDA approval · 2021-04-23FDA Approved: TERIFLUNOMIDE — Supplemental Application (MSN LABORATORIES PRIVATE LIMITED)
FDA approved a supplemental application for teriflunomide from MSN Laboratories Private Limited, enabling the marketing of a generic version…
-
FDA approval · 2021-04-07FDA Approved: TERIFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic teriflunomide from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating repeated administrations of mesenchymal stem cells in patients with progressive multiple scl…
-
FDA approval · 2021-03-29FDA Approved: TERIFLUNOMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for teriflunomide from Mylan Pharmaceuticals Inc., indicating an approved update to the product prev…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of MS [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating mesenchymal stem cells for treating multiple sclerosis has completed.
-
FDA approval · 2021-03-26FDA Approved: DIMETHYL FUMARATE — Original Application (SOLA Pharmaceuticals, LLC)
The FDA approved SOLA Pharmaceuticals, LLC's Original Application for dimethyl fumarate, a generic version indicated for relapsing forms of …
-
FDA approval · 2021-03-18FDA Approved: PONVORY — Original Application (Janssen Pharmaceuticals, Inc)
FDA approves PONVORY (ponesimod) from Janssen as the original approval for treatment of adults with relapsing forms of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis [NA]
A completed clinical trial evaluating cognitive behavioural therapy software for treating depression in people with multiple sclerosis; resu…
-
FDA approval · 2021-03-05FDA Approved: FINGOLIMOD — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' generic fingolimod under an Original Application, making a generic version of fingolimod available fo…
-
FDA approval · 2021-03-05FDA Approved: BACLOFEN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic baclofen (oral) by Rising Pharma Holdings, Inc. The approval covers use for management o…
-
FDA approval · 2021-02-24FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
FDA approved a Supplemental Application for AMPYRA (dalfampridine) submitted by Merz Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis [Phase 3]
Phase 3 trial update on arbaclofen placarbil for spasticity in multiple sclerosis reports efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks [Phase 4]
Long-term, open-label Phase 4 study assessing cardiovascular risks in multiple sclerosis patients has completed with results posted.